PATENT CLAIM ANALYSIS

Application Number: 15750788
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["424", "164100"]

Abstract:
Described herein are engineered microbe-targeting molecules, microbe-targeting articles, kits comprising the same, and uses thereof. Such microbe-targeting molecules, microbe-targeting articles, or the kits comprising the same can not only bind or capture of a microbe or microbial matter thereof, but they also have improved capability (e.g., enhanced sensitivity or signal intensity) of detecting a microbe or microbial matter. Thus, the microbe-targeting molecules, microbe-targeting articles, and/or the kit described herein can be used in various applications, e.g., but not limited to assays for detection of a microbe or microbial matter, diagnostic and/or therapeutic agents for diagnosis and/or treatment of an infection caused by microbes in a subject or any environmental surface, and/or devices for removal of a microbe or microbial matter from a fluid.

Claim (Index 9):
The microbe-binding molecule of  claim 1 , wherein the collagen domain comprise a plurality of Gly-Xaa 1 -Xaa 2  triplets, wherein Xaa 1  and Xaa 2  are each independently an amino acid residue.

Metadata:
- Claim Count in Document: 58.0
- Percentile: 88.0
- Lexical Diversity: 1.91892
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15415352', '14233553', '15105298', '14382043', '14766575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7426692304658029
- 35 USC 102 Novelty (BERT): 0.5525618231436347
- Combined Prediction Score: 0.7236584897335862
- Mean Citation Score: 356.943714
- Max Citation Score: 415.74106
- Similarity Product: 278.3293691379023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test